EUROCONFERENCES
Que sont les EUROCONFERENCES ?
What are the EUROCONFERENCES ?
EUROCONFERENCES passées

Mastering anti-infective therapies

Maîtrise des agents anti-infectieux

Extensive Abstracts / Résumés étendus


Why do we need to master anti-infective therapies? And why to we need new ones?
Olivier Lortholary,
Hôpital Necker & Institut Pasteur, Paris, France

Determinants of anti-infective prescribing: patients' and clinicians' perspectives
Christopher C. Butler,
Cardiff University, UK

Impact of health care systems on drug use
Kathleen Holloway,
WHO, Geneva, CH

Anti-infective usage in animals - a risk for human health?
Christina Greko,
National Veterinary Institute, Uppsala, Sweden

Impact of microbial resistance on clinical outcome and health expenses
Yehuda Carmeli,
Tel Aviv Medical Center, Israel

Pharmaceutical promotion and prevention of antibiotic resistance
Barbara Mintzes
, University of Sussex, Brighton, UK

Education and decision making
Roger Finch,
University of Nottingham, UK

Bringing new anti-infectives to the patients - Role of the industry
Goran A. Ando,
Novexel SA, Romainville, France

The individual impact of antibiotic usage
Fernando Baquero,
Ramón y Cajal University Hospital, Madrid, Spain

Surveillances of antibiotic resistance: can the results be misleading?
S. Ragnar Norrby,
Swedish Inst. for Infectious Disease Controle, Solna, Sweden

Strategies to improve the use of medicines: what makes them effective and sustainable?
Sri Suryawati
, Gadjah Mada University, Yogyakarta, Indonesia

Revolutionizing the diagnostic of infectious diseases with SMART CDs that "read" DNA in a few minutes
Michel G. Bergeron,
Laval University, Sainte-Foy, Canada

Evaluation of the selective potential for resistance to antibacterial agents
Antoine Andremont,
Groupe Hospitalier Bichat-Claude Bernard, Paris, France

Is there a critical need for continued discovery and development of anti-infectives? A pharmaceutical company perspective
Christopher A. Hitchcock,
Pfizer Global Research R & D, Sandwich, UK

Preserving the power of antimicrobials: The U.S. Government response
J. Todd Weber,
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, USA

The ECDC views towards an european strategy
Peet Tüll,
ECDC, Solna, Sweden